Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections

Due to the lack of an effective therapeutic treatment to flavivirus, dengue virus (DENV) nonstructural protein 1 (NS1) has been considered to develop a vaccine owing to its lack of a role in antibody-dependent enhancement (ADE). However, both NS1 and its antibody have shown cross-reactivity to host...

Descripción completa

Detalles Bibliográficos
Autores principales: Sootichote, Rochanawan, Puangmanee, Wilarat, Benjathummarak, Surachet, Kowaboot, Siriporn, Yamanaka, Atsushi, Boonnak, Korbporn, Ampawong, Sumate, Chatchen, Supawat, Ramasoota, Pongrama, Pitaksajjakul, Pannamthip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855337/
https://www.ncbi.nlm.nih.gov/pubmed/36672734
http://dx.doi.org/10.3390/biomedicines11010227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855337/
https://www.ncbi.nlm.nih.gov/pubmed/36672734
http://dx.doi.org/10.3390/biomedicines11010227

Ejemplares similares